Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $27.5000 (-2.65%) ($27.3000 - $28.4500) on Thu. Jan. 18, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.25% (three month average) | RSI | 87 | Latest Price | $27.5000(-2.65%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 5.4% a day on average for past five trading days. | Weekly Trend | ATRA advances 27.1% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(58%) ARKG(51%) IBB(51%) IWO(50%) ARKK(48%) | Factors Impacting ATRA price | ATRA will decline at least -2.625% in a week (0% probabilities). VIXM(-15%) TLT(-14%) UUP(-12%) VXX(-4%) UNG(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.625% (StdDev 5.25%) | Hourly BBV | 0 () | Intraday Trend | -2.5% | | | |
|
5 Day Moving Average | $26.74(2.84%) | 10 Day Moving Average | $23.13(18.89%) | 20 Day Moving Average | $19.84(38.61%) | To recent high | -2.7% | To recent low | 108.3% | Market Cap | $2.043b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |